The William and Ella Owens Medical Research Foundation recently awarded $1.5 million to The University of Texas Health Science Center at San Antonio (UT Health San Antonio) for research projects that address pancreatic cancer, Alzheimer’s disease and childhood cancers. This year, the foundation will fund $250,000 each to six research projects from UT Health […]

Scientists at The University of Texas Health Science Center at San Antonio have made one of the most important discoveries to date in the study and treatment of BRCA1-deficient cancers and drug resistance.

  The University of Texas Health Science Center at San Antonio (UT Health San Antonio) received $3,395,970 in new academic research and prevention awards as part of the latest $98 million funding round announced on May 21 by the Cancer Prevention and Research Institute of Texas (CPRIT). The state agency, which focuses on funding evidence-based […]

Nina Murray admits she was “one of those people” who rarely went to the dentist. But going, when she did, might have saved her life. Last September, she detected what she first thought was an ulcer inside her right cheek, but it quickly turned into a hard lump and started hurting. “Something’s not right,” she […]

Discovery of chemical endocytosis could redefine precision medicine A team of scientists, notably Zhengyu Wang, PhD, assistant professor in the department of pharmacology and the Barshop Institute, led by Hong-yu Li, PhD, professor of medicinal chemistry and chemical biology with the department of pharmacology and the Barshop Institute at The University of Texas Health Science […]

On April 5, more than a thousand participants gathered for the annual Give Cancer the Boot Survivorship 5K and 1-Mile Walk, dedicated to honoring survivors and supporting those still in treatment.

BRCA1 and BRCA2 are genes that help protect the body by fixing damaged DNA and keeping cells healthy. When these genes have changes, or mutations, they don’t work the way they should. This can raise the risk of certain cancers, like breast, ovarian, prostate and pancreatic cancer. These inherited mutations affect about 1 in every 200 to 300 people — over a million in the U.S. alone.

Alicia Logue, MD, associate professor, Department of Surgery, was interviewed for this episode of The Source.   Listen Now

Mays Cancer Center offers a survivorship program to patients to prevent cancer from reoccurring through interventions and surveillance to help them live well after treatment.

Learn about Mays Cancer Center’s cardio-oncology program and what cancer patients who have cardiovascular conditions can expect.